Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04240704
Title Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries USA | ESP | DEU

Facility Status City State Zip Country Details
Mayo Clinic Arizona Withdrawn Phoenix Arizona 85054 United States Details
Mayo Clinic Rochester Withdrawn Rochester Minnesota 55905 United States Details
Medical College of Wisconsin Withdrawn Milwaukee Wisconsin 53226 United States Details
Novartis Investigative Site Recruiting HUS FIN-00029 Finland Details
Novartis Investigative Site Recruiting Dresden 01307 Germany Details
Novartis Investigative Site Recruiting Freiburg 79106 Germany Details
Novartis Investigative Site Recruiting Tel Aviv 6423906 Israel Details
Novartis Investigative Site Recruiting Chuo ku Tokyo 104 0045 Japan Details
Novartis Investigative Site Recruiting Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Recruiting Singapore 169608 Singapore Details
Novartis Investigative Site Recruiting Barcelona Catalunya 08035 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field